Evoke Pharma Inc. (EVOK)

AI Score

Unlock

2.46

0.13 (5.62%)

At close: Apr 22, 2025, 3:59 PM

2.40

-2.44%

After-hours: Apr 22, 2025, 06:22 PM EDT

Evoke Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Net Income	-5.35M	-6.15M	-6.53M	-7.13M	-7.79M	-7.61M	-7.93M	-8.29M	-8.22M	-8.09M	-8.05M	-8.11M	-8.54M	-9.13M	-9.29M	-13.97M	-13.15M	-12.31M	-11.8M	-6.95M	-7.13M	-7.47M	-7.36M	-7.55M	-7.57M	-6.11M	-9.84M	-9.16M	-12.23M	-13.45M	-11.23M	-12.58M	-10.75M	-11.85M	-11.56M	-11.83M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	773.12K	793.83K	944K	1.1M	1.13M	1.2M	1.28M	1.36M	1.46M	1.56M	1.67M	1.7M	1.88M	1.9M	1.92M	1.88M	1.63M	1.47M	1.32M	1.31M	1.37M	1.43M	1.48M	1.52M	1.54M	1.58M	1.67M	1.75M	1.82M	1.81M	1.79M	1.75M	1.71M	1.67M	1.59M	1.55M
Other Working Capital	511.79K	988.8K	-133.59K	-380.75K	556.12K	-412.39K	-440.8K	-94K	48.49K	276.91K	277.9K	-97.94K	-797.02K	4.37M	3.99M	4.03M	4.72M	490.85K	52.96K	-31.89K	-116.68K	572.67K	848.86K	789.35K	730.73K	-1.34M	-732.74K	-1.23M	-1.21M	763.71K	584.58K	1.27M	1.23M	216.38K	-76.95K	-200.84K
Other Non-Cash Items	758.49K	629.15K	1.49M	1.01M	129.07K	140.3K	321.89K	716.99K	1.13M	1.13M	1.43M	993.86K	442.93K	-4.64M	-5.11M	-104.17K	-140.94K	4.63M	5.45M	448.22K	106.28K	407.67K	-116.73K	-44.02K	5.47K	-2.37M	-1.17M	-2.5M	1.01M	2.56M	1.85M	3.12M	56.97K	860.8K	40.32K	42.06K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-450.92K	586.29K	-265.53K	-118.05K	1.55M	-118.83K	94.86K	244.76K	132.41K	406.05K	-4.53M	-4.64M	-5.62M	323.15K	4.5M	4.16M	4.9M	-285.14K	165.97K	258.44K	-10.4K	171.44K	-76.77K	-63.57K	-518.56K	-1.14M	-108.83K	63.94K	687.83K	1.72M	23.4K	-313	277.3K	-480.86K	44.17K	41.43K
Operating Cash Flow	-5.46M	-5.32M	-5.55M	-5.93M	-4.98M	-6.39M	-6.44M	-6.61M	-6.6M	-6.09M	-10.88M	-11.01M	-12.35M	-12.07M	-7.99M	-8.03M	-6.63M	-6.07M	-5.31M	-5.39M	-5.76M	-5.86M	-5.95M	-6.09M	-6.98M	-8.46M	-9.51M	-9.85M	-8.72M	-7.35M	-7.57M	-7.7M	-8.71M	-9.79M	-9.88M	-10.19M
Capital Expenditures	n/a	n/a	-5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3M	3M	3M	3M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.71M	2.71M	2.71M	2.71M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.5K	-2.5K	-2.5K	-2.5K	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	7.6M	3.98M	1M	705.21K	-119.3K	-148.99K	n/a	-148.99K	-148.99K	313.11K	164.11K	-946.28K	-946.28K	-1.05M	-945.41K	5.73M	5.75M	5.54M	5.43M	21.25K	n/a	n/a	n/a	n/a	n/a	-54.36K	-54.36K	-54.36K	-54.36K	n/a	-4.5M	-4.5M	-4.5M	-4.5M	n/a	n/a
Financial Cash Flow	14.32M	10.7M	7.72M	7.42M	-119.3K	7.29K	7.29K	7.13M	7.3M	7.29M	7.61M	530.08K	13.43M	16.93M	16.72M	22.08M	9.04M	5.84M	5.87M	5.49M	6.11M	5.8M	6.86M	4.71M	4.62M	4.62M	3.49M	599K	7.39M	7.39M	16M	16.26M	9.02M	9.43M	4.12M	4.6M
Net Cash Flow	8.86M	5.37M	2.17M	1.49M	-5.1M	-6.39M	-6.44M	511.6K	698.99K	1.21M	-3.27M	-10.48M	1.08M	4.86M	8.73M	14.05M	2.41M	-224.15K	550.31K	104.64K	344.83K	-63.12K	909K	-1.38M	-2.36M	-3.85M	-6.03M	-9.25M	-1.33M	33.09K	8.43M	8.56M	315.92K	-358.94K	-5.75M	-5.59M
Free Cash Flow	-5.46M	-5.32M	-5.55M	-5.93M	-4.98M	-6.39M	-6.44M	-6.61M	-6.6M	-6.09M	-10.88M	-11.01M	-12.35M	-12.07M	-7.99M	-8.03M	-6.63M	-6.07M	-5.31M	-5.39M	-5.76M	-5.86M	-5.95M	-6.09M	-6.98M	-8.46M	-9.51M	-9.85M	-8.72M	-7.35M	-7.57M	-7.7M	-8.71M	-9.79M	-9.88M	-10.19M